| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/16/2013 | CN102871985A Hemoglobin microcapsule blood substitute and its preparation method |
| 01/16/2013 | CN102871969A Application of erythropoietin microspheres to preparation of drugs for treating motor complications in Parkinson's disease |
| 01/16/2013 | CN102870971A Pig anti-stress preparation |
| 01/16/2013 | CN102228469B Nano-selenium particles and preparation method thereof |
| 01/16/2013 | CN102228425B Tumor-targeted magnetic hydrogel nanoscale medicine delivery system and construction method and application thereof |
| 01/16/2013 | CN102154301B Preparation and application of conotoxin striatus S21a in South China Sea |
| 01/16/2013 | CN102133394B Compound insulin preparation |
| 01/16/2013 | CN101985464B High-stability PAC1 type receptor specific agonist MPAPO and preparation method and application thereof |
| 01/16/2013 | CN101948543B Fusion protein and coding gene and application thereof |
| 01/16/2013 | CN101670096B Medicinal preparation containing exenatide |
| 01/16/2013 | CN101501067B Diuretic and natriuretic polypeptides |
| 01/16/2013 | CN101497671B 羟烷基淀粉衍生物 Hydroxyalkyl starch derivative |
| 01/16/2013 | CN101411876B Neurotoxic oligomers |
| 01/16/2013 | CN101341168B Metastin derivatives and use thereof |
| 01/16/2013 | CN101325944B Compositions for nasal delivery |
| 01/16/2013 | CN101306191B Use of TLR2 ligand PGN in treating metabolism syndrome |
| 01/15/2013 | US8354513 Polynucleotides encoding BSL2vcvc-lg |
| 01/15/2013 | US8354503 Method for extracting hydrophobin from a solution |
| 01/15/2013 | US8354502 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 01/15/2013 | US8354501 Methods for stepwise deposition of silk fibroin coatings |
| 01/15/2013 | US8354496 Isoforms of brain natriuretic peptide |
| 01/15/2013 | US8354448 Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes |
| 01/15/2013 | US8354381 Peptide compositions for oral care systems |
| 01/15/2013 | US8354379 Peptides that enhance acetylcholinesterase expression |
| 01/15/2013 | US8354378 G protein coupled receptor antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
| 01/15/2013 | US8354377 Use of factor VIIa or factor VIIa equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ICH) in a selected subpopulation of ICH patients |
| 01/15/2013 | US8354376 Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
| 01/15/2013 | US8354375 Repair of ligament using osteogenic proteins |
| 01/15/2013 | US8354374 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |
| 01/15/2013 | US8354373 Compounds having an isolated peptide consisting of structure (I) |
| 01/15/2013 | US8354372 Cyclised alpha-conotoxin peptides |
| 01/15/2013 | US8354370 Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders |
| 01/15/2013 | US8354268 Protein glycosylation modification in methylotrophic yeast |
| 01/15/2013 | US8354241 Methods for identifying a GLP-1 secretagogue |
| 01/15/2013 | US8354125 Ex-vivo treatment of peripheral blood leukocytes with IFN-λ |
| 01/15/2013 | US8354119 Utilized as a scaffold implant for vertebral or meniscal cartilage regeneration. |
| 01/15/2013 | US8354115 Binding proteins; vaccines; increased cytokine and antibody production |
| 01/15/2013 | US8354111 Stable cell binding chimeric peptides |
| 01/15/2013 | US8354101 Pullulanase variants with increased productivity |
| 01/15/2013 | DE202012011337U1 Arzneimittel gegen Krebs, Herzinfarkt und Tuberkulose sowie gegen sämtliche Krankheiten Medicines to treat cancer, heart attack and tuberculosis, and treat all diseases |
| 01/15/2013 | CA2631587C Chemokine-mucin fusions linked to glycosylphosphatidylinositol (gpi)-anchors in tissue regeneration and as tumour immune adjuvants |
| 01/15/2013 | CA2550583C Modified cea /b7 vector |
| 01/15/2013 | CA2529828C Factor vii or viia gla domain variants |
| 01/15/2013 | CA2502251C Method of treatment of psychological conditions by administration of nerve growth factor |
| 01/15/2013 | CA2468582C Materials and methods for making improved micelle compositions |
| 01/15/2013 | CA2406725C Edg8 receptor, its preparation and use |
| 01/15/2013 | CA2400842C Novel compounds |
| 01/15/2013 | CA2346131C Method for improving the pharmacokinetics of tipranavir |
| 01/10/2013 | WO2013006841A1 Stimulation of arterial collateral growth and lymphogenesis |
| 01/10/2013 | WO2013006766A2 Formulations that stabilize proteins |
| 01/10/2013 | WO2013006558A2 Compositions and methods for treating skeletal myopathy |
| 01/10/2013 | WO2013006514A2 Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases |
| 01/10/2013 | WO2013006454A1 Arginine - free tnfr : fc- fusion polypeptide compositions and methods of use |
| 01/10/2013 | WO2013006436A1 Acsf3 mutations in metabolic disorders |
| 01/10/2013 | WO2013006402A1 Methods and compositions for facilitating weight loss by administration of thyroid hormones |
| 01/10/2013 | WO2013006230A2 Combined inhibition of the vitamin d receptor and dna replication in the treatment of cancer |
| 01/10/2013 | WO2013006129A1 Treatment of prostate cancer and a method for determining the prognosis for prostate cancer patients |
| 01/10/2013 | WO2013006076A1 The use of intranasally administered hsp70 protein to treat neurodegenerative diseases |
| 01/10/2013 | WO2013005839A1 Phosphorylated peptide, hard tissue and/or ectopic calcification inhibitor, antibody, and hard tissue and/or ectopic calcification promoter |
| 01/10/2013 | WO2013005603A1 Agent for prevention and/or treatment of allergic inflammation in conjunctiva |
| 01/10/2013 | WO2013005042A2 Anti-viral therapy |
| 01/10/2013 | WO2013004845A1 Cyclic tripeptide mimetics as plasmin inhibitors |
| 01/10/2013 | WO2013004838A1 Formulations for wound therapy |
| 01/10/2013 | WO2013004399A1 Anti - amyloidogenic, alpha-helix breaking ultra-small peptide therapeutics |
| 01/10/2013 | WO2013004203A1 Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases |
| 01/10/2013 | WO2013004069A1 Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases |
| 01/10/2013 | WO2013003987A1 Tumor-targeted tumor necrosis factor-related apoptosis ligand variant and use thereof |
| 01/10/2013 | WO2012158965A3 Improved peptide pharmaceuticals for insulin resistance |
| 01/10/2013 | WO2012158964A3 Improved peptide pharmaceuticals for osteoporosis |
| 01/10/2013 | WO2012158776A3 Combination therapy for treatment of cancer |
| 01/10/2013 | WO2012158493A3 Compounds that bind to the erythropoietin receptor |
| 01/10/2013 | WO2012149416A3 Human myeloid derived suppressor cell cancer markers |
| 01/10/2013 | WO2012126899A3 Inhibition and treatment of biofilms |
| 01/10/2013 | WO2012125872A3 Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof |
| 01/10/2013 | WO2012115772A3 Therapy for kidney disease and/or heart failure |
| 01/10/2013 | WO2012048334A3 Novel fungal proteases |
| 01/10/2013 | US20130013334 Methods for the identification, assessment, and treatment of patients with cancer therapy |
| 01/10/2013 | US20130012567 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/10/2013 | US20130012457 Beta sheet tapes ribbons in tissue engineering |
| 01/10/2013 | US20130012456 Compositions and methods for transport across the blood brain barrier |
| 01/10/2013 | US20130012455 Use of ARC for inhibiting cell death during liver failure |
| 01/10/2013 | US20130012454 Orally Disintegrating Compositions of Linaclotide |
| 01/10/2013 | US20130012453 Acceleration Of Wound Healing By A Tissue Inhibitor Of Metalloproteinases (TIMP) Linked To Glycosylphosphatidylinositol (GPI)-Anchors |
| 01/10/2013 | US20130012452 Method for treating brain cancer using a novel tumor suppressor gene and secreted factor |
| 01/10/2013 | US20130012451 Compositions and methods for inhibiting mmp-9-mediated cell migration |
| 01/10/2013 | US20130012450 Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Dermatology Related Genetic Diseases |
| 01/10/2013 | US20130012449 Solvent-free process for obtaining phospholipids and neutral enriched krill oils |
| 01/10/2013 | US20130012448 Synthetic peptide amides |
| 01/10/2013 | US20130012447 Protein kinase c-delta inhibitors that protect against cellular injury and inflammation and promote astrocyte proliferation |
| 01/10/2013 | US20130012445 Compositions for Improving Bone Mass |
| 01/10/2013 | US20130012444 Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012443 Methods of treatment of central nervous system hemorrhage using protoporphyrin ix-fe compounds |
| 01/10/2013 | US20130012442 Von willebrand factor- and factor viii-polymer conjugates having a releasable linkage |
| 01/10/2013 | US20130012441 Prediction and prevention of preeclampsia |
| 01/10/2013 | US20130012440 Preventive and/or therapeutic and/or aggravation suppressing agent for human arthritis deformans |
| 01/10/2013 | US20130012439 Composition for nasal administration and method for preparing same |
| 01/10/2013 | US20130012438 Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| 01/10/2013 | US20130012437 Lytic peptides having anti-proliferative activity against prostate cancer cells |
| 01/10/2013 | US20130012436 Fibronectin based scaffold domain proteins that bind il-23 |
| 01/10/2013 | US20130012435 Multivalent fibronectin based scaffold domain proteins |